Severe hypercalcaemia revealing sarcoidosis precipitated by etanercept;Hypercalcémie majeure révélatrice d'une sarcoïdose induite par étanercept

Revue des Maladies Respiratoires

Volumn 31, Issue 3, 2014, Pages 255-258

  Watrin, A ^a,b   Royer, M ^a,b   Legrand, E ^a,b   Gagnadoux, F ^a,b  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b Laboratoire d'Acoustique Environnementale)   (France)

Author keywords

Anti TNF; Etanercept; Hypercalcaemia; Sarcoidosis; Splenomegaly

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; ETANERCEPT; ANTIRHEUMATIC AGENT; IMMUNOGLOBULIN G; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BRONCHUS BIOPSY; CASE REPORT; CORTICOSTEROID THERAPY; DISEASE SEVERITY; FEMALE; HUMAN; HYPERCALCEMIA; REHYDRATION; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SPLENOMEGALY; TREATMENT DURATION; VOMITING; ARTHRITIS, RHEUMATOID; CHEMICALLY INDUCED;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; HYPERCALCEMIA; IMMUNOGLOBULIN G; RECEPTORS, TUMOR NECROSIS FACTOR; SARCOIDOSIS; SPLENOMEGALY;

EID: 84901232283     PISSN: 07618425     EISSN: 17762588     Source Type: Journal    
DOI: 10.1016/j.rmr.2013.04.029     Document Type: Article

References (20)

1. T. Ishiguro N. Takayanagi K. Kurashima, et al. Development of sarcoidosis during etanercept therapy Intern Med 47 2008 1021 1025
2. F. Jounieaux C. Chapelon D. Valeyre, et al. Infliximab et sarcoïdose chronique. L'expérience française à propos de 31 cas Rev Mal Respir 27 2010 685 692
3. A. Massara L. Cavazzini R. La Corte, et al. Sarcoidosis appearing during anti-tumor necrosis factor alpha therapy: a new g-class effectg- paradoxical phenomenon. Two case reports and literature review Semin Arthritis Rheum 39 2010 313 319
4. L. Javot S. Tala J. Scala-Bertola, et al. Sarcoïdosis and anti-TNF: a paradoxical class effect? Analysis of the French pharmacovigilance system database and literature review Therapie 66 2011 149 154
5. M. Kerjouan S. Jouneau H. Lena, et al. Sarcoïdose pulmonaire apparue sous étanercept Rev Mal Respir 28 2011 360 364
6. D. Tong N. Manolios G. Howe, et al. New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication Intern Med J 42 2012 89 94
7. M.C. Iannuzzi B.A. Rybicki A.S. Teirstein Sarcoidosis N Engl J Med 357 2007 2153 2165
8. C. Chapelon-Abric Épidémiologie de la sarcoïdose et ses facteurs de risque génétiques et environnementaux Rev Med Interne 25 2004 494 500 (Pubitemid 38813435)
9. R. Karnchanasorn M. Sarikonda S. Aldasouqi, et al. Severe hypercalcemia and acute renal failure: an unusual presentation of sarcoidosis Case Report Med 2010 423659
10. S. Madaule D. Lauque L. Sailler, et al. Les splénomégalies sarcoïdosiques: caractéristiques cliniques et évolutives. À propos de 17 observations Rev Med Interne 25 2004 348 356 (Pubitemid 38542844)
11. Ishiguro T, Takayanagi N, Kurashima K, et al. Develop-ment of sarcoidosis during etanercept therapy. Intern Med2008;47:1021-5
12. Jounieaux F, Chapelon C, Valeyre D, et al. Infliximab et sarcoï-dose chronique. L'expérience française À propos de 31 cas. RevMal Respir 2010;27:685-92
13. Massara A, Cavazzini L, La Corte R, et al. Sarcoidosis appea-ring during anti-tumor necrosis factor alpha therapy: a new''class effect'' paradoxical phenomenon. Two case reports andliterature review. Semin Arthritis Rheum 2010;39:313-9
14. Javot L, Tala S, Scala-Bertola J, et al. Sarcoïdosis and anti-TNF:a paradoxical class effect? Analysis of the French pharma-covigilance system database and literature review. Therapie2011;66:149-54
15. Kerjouan M, Jouneau S, Lena H, et al. Sarcoïdose pulmonaireapparue sous étanercept. Rev Mal Respir 2011;28:360-4
16. Tong D, Manolios N, Howe G, et al. New onset sarcoid-likegranulomatosis developing during anti-TNF therapy: an under-recognised complication. Intern Med J 2012;42:89-94
17. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med2007;357:2153-65
18. Chapelon-Abric C. Épidémiologie de la sarcoïdose et ses fac-teurs de risque génétiques et environnementaux. Rev MedInterne 2004;25:494-500 (Pubitemid 38813435)
19. Karnchanasorn R, Sarikonda M, Aldasouqi S, et al. Severe hyper-calcemia and acute renal failure: an unusual presentation ofsarcoidosis. Case Report Med 2010:423659
20. Madaule S, Lauque D, Sailler L, et al. Les splénomégalies sar-coïdosiques : caractéristiques cliniques et évolutives. À proposde 17 observations. Rev Med Interne 2004;25:348-56